Orchard Therapeutics PLC Probability of Future Stock Price Finishing Over 5.36
Orchard Therapeutics' future price is the expected price of Orchard Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Orchard Therapeutics PLC performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please specify Orchard Therapeutics' target price for which you would like Orchard Therapeutics odds to be computed.
Orchard |
Orchard Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orchard Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orchard Therapeutics PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orchard Therapeutics is not yet fully synchronised with the market data | |
| Orchard Therapeutics has some characteristics of a very speculative penny stock | |
| Orchard Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 21.84 M. Net Loss for the year was (72.92 M) with loss before overhead, payroll, taxes, and interest of (76.52 M). | |
| Orchard Therapeutics PLC currently holds about 170.89 M in cash with (93.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.35. | |
| Over 88.0% of the company shares are owned by institutional investors |
Orchard Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orchard Stock often depends not only on the future outlook of the current and potential Orchard Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orchard Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.8 M | |
| Cash And Short Term Investments | 143.8 M |
Orchard Therapeutics Technical Analysis
Orchard Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Orchard Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orchard Therapeutics PLC. In general, you should focus on analyzing Orchard Stock price patterns and their correlations with different microeconomic environments and drivers.
Orchard Therapeutics Predictive Forecast Models
Orchard Therapeutics' time-series forecasting models is one of many Orchard Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orchard Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orchard Therapeutics PLC
Checking the ongoing alerts about Orchard Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orchard Therapeutics PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orchard Therapeutics is not yet fully synchronised with the market data | |
| Orchard Therapeutics has some characteristics of a very speculative penny stock | |
| Orchard Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 21.84 M. Net Loss for the year was (72.92 M) with loss before overhead, payroll, taxes, and interest of (76.52 M). | |
| Orchard Therapeutics PLC currently holds about 170.89 M in cash with (93.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.35. | |
| Over 88.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |